Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Helena Mikazane"'
Autor:
Natalja Kakurina, Anda Kadisa, Aivars Lejnieks, Helena Mikazane, Svetlana Kozireva, Modra Murovska
Publikováno v:
Medicina, Vol 51, Iss 1, Pp 18-24 (2015)
Background and objective: We evaluated a possible correlation between the clinical activities of rheumatoid arthritis (RA) and human parvovirus B19 (B19) infection using exploratory factor analysis (EFA). Materials and methods: RA patients were organ
Externí odkaz:
https://doaj.org/article/32e5df126c6b420783f8651aaddfeaef
Publikováno v:
Jurnalul de Chirurgie. 14
Publikováno v:
International Journal of Clinical Rheumatology. 13
Background: Chronic venous insufficiency (CVI) may lead to leg ulceration (CVI stage C6) (Nicolaides A.N. et al., 2000). Some authors published that genetic risk factors are observed more frequently in patients with CVI stage C6. Also, an increased l
Publikováno v:
Journal of Arthritis.
Introduction: Carotid ultrasound based on assessment of intima media thickness (IMT) and presence of plaques has been considered to be a cheap and efficient way to measure clinical atherosclerosis. Both carotid IMT and carotid plaques have been prove
Autor:
Volodymyr Kovalenko, Sławomir Jeka, Ho Ung Kim, Pedro Miranda, Yeon Ah Lee, Jürgen Braun, Grygorii Lysenko, Dae Hyun Yoo, Helena Mikazane, Sang Joon Lee, Mie Jin Lim, Sergio Gutierrez-Ureña, Won Park, Paweł Hrycaj
Publikováno v:
Annals of the Rheumatic Diseases
Objectives To compare the pharmacokinetics (PK), safety and efficacy of innovator infliximab (INX) and CT-P13, a biosimilar to INX, in patients with active ankylosing spondylitis (AS). Methods Phase 1 randomised, double-blind, multicentre, multinatio
Autor:
Mie Jin Lim, Sergio Gutierrez-Ureña, Marek Brzosko, Helena Mikazane, Yeon Ah Lee, Jürgen Braun, Piotr Wiland, Vladimir Kadinov, Yunju Bae, Svitlana Smiyan, HoUng Kim, Suyeon Kim, Pedro Miranda, Carlos Abud-Mendoza, Sang Joon Lee, Won Park, Dae Hyun Yoo
Publikováno v:
Annals of the Rheumatic Diseases
ObjectivesTo investigate the efficacy and safety of switching from infliximab reference product (RP) to its biosimilar or maintaining biosimilar treatment in patients with ankylosing spondylitis (AS).MethodsThis open-label extension study recruited p